-
(2S,5R,6R)-6-(2-carboxy-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
-
ChemBase ID:
460
-
Molecular Formular:
C17H18N2O6S
-
Molecular Mass:
378.39962
-
Monoisotopic Mass:
378.08855731
-
SMILES and InChIs
SMILES:
S1[C@H]2N([C@H](C1(C)C)C(=O)O)C(=O)[C@H]2NC(=O)C(c1ccccc1)C(=O)O
Canonical SMILES:
O=C(C(c1ccccc1)C(=O)O)N[C@@H]1C(=O)N2[C@@H]1SC([C@@H]2C(=O)O)(C)C
InChI:
InChI=1S/C17H18N2O6S/c1-17(2)11(16(24)25)19-13(21)10(14(19)26-17)18-12(20)9(15(22)23)8-6-4-3-5-7-8/h3-7,9-11,14H,1-2H3,(H,18,20)(H,22,23)(H,24,25)/t9?,10-,11+,14-/m1/s1
InChIKey:
FPPNZSSZRUTDAP-UWFZAAFLSA-N
-
Cite this record
CBID:460 http://www.chembase.cn/molecule-460.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(2S,5R,6R)-6-(2-carboxy-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
|
|
|
IUPAC Traditional name
|
|
Brand Name
|
|
Synonyms
|
Carboxybenzylpenicillin acid
|
Carboxybenzylpenicillin
|
Carbenicillinum [INN-Latin]
|
Carbenicilline [INN-French]
|
Carbenicillina [DCIT]
|
Carbenicilina [INN-Spanish]
|
alpha-Carboxybenzylpencillin
|
Carbenicillin
|
α-Carboxybenzylpenicillin solution
|
Carbenicillin
|
Carbenicillin
|
Klebsiella Selective Supplement
|
α-Carboxybenzylpenicillin 溶液
|
羧苄青霉素
|
羧苄青霉素
|
克雷伯氏菌选择性添加剂
|
|
|
CAS Number
|
|
EC Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
ALOGPS 2.1
Acid pKa
|
3.1068087
|
H Acceptors
|
6
|
H Donor
|
3
|
LogD (pH = 5.5)
|
-3.1951313
|
LogD (pH = 7.4)
|
-5.9115877
|
Log P
|
0.81535685
|
Molar Refractivity
|
90.8195 cm3
|
Polarizability
|
35.8031 Å3
|
Polar Surface Area
|
124.01 Å2
|
Rotatable Bonds
|
5
|
Lipinski's Rule of Five
|
true
|
Log P
|
1.13
|
LOG S
|
-2.99
|
Solubility (Water)
|
3.90e-01 g/l
|
DETAILS
DETAILS
DrugBank
Sigma Aldrich
DrugBank -
DB00578
|
Item |
Information |
Drug Groups
|
approved |
Description
|
Broad-spectrum semisynthetic penicillin derivative used parenterally. It is susceptible to gastric juice and penicillinase and may damage platelet function. [PubChem] |
Indication |
For the treatment of acute and chronic infections of the upper and lower urinary tract and in asymptomatic bacteriuria due to susceptible strains of bacteria. |
Pharmacology |
Carbenicillin is a semisynthetic penicillin. Though carbenicillin provides substantial in vitro activity against a variety of both gram-positive and gram-negative microorganisms, the most important aspect of its profile is in its antipseudomonal and antiproteal activity. Because of the high urine levels obtained following administration, carbenicillin has demonstrated clinical efficacy in urinary infections due to susceptible strains of: Escherichia coli, Proteus mirabilis, Proteus vulgaris, Morganella morganii, Pseudomonas species, Providencia rettgeri, Enterobacter species, and Enterococci (S. faecalis). |
Toxicity |
Carbenicillin blood levels achievable are very low, and toxic reactions as a function of overdosage should not occur systematically. The oral LD50 in mice is 3,600 mg/kg, in rats 2,000 mg/kg, and in dogs is in excess of 500 mg/kg. The lethal human dose is not known. Symptoms of overdose include diarrhea, nausea, stomach upset, and vomiting. |
Affected Organisms |
• |
Enteric bacteria and other eubacteria |
|
Biotransformation |
Minimal. |
Absorption |
Rapidly absorbed from the small intestine following oral administration. Oral bioavailability is 30 to 40%. |
Half Life |
1 hour |
Protein Binding |
30 to 60% |
External Links |
|
|
Sigma Aldrich -
C1613
|
Application Used for selection of ampr transformed cells. Use to study the role of penicillin-sensitive transpeptidases in cell wall biosynthesis. Biochem/physiol Actions The antibiotic carbenicillin, an ampicillin analog, is a commonly used selection agent that binds and inhibits enzymes involved in the synthesis of the bacterial cell wall. It is active against most isolates of Pseudomonas aerogenosa and certain indole-positive Proteus strains that are resistant to ampicillin. The gene conferring resistance to ampicillin and its analogs, ampr, codes for the enzyme β-lactamase. Carbenicillin is less sensitive to β-lactamase than ampicillin. In addition it has a superior stability at low pH. Experiments have shown that the use of carbenicillin in place of ampicillin helps prevent overgrowth of satellite colonies. Effective concentration: 50 to 100 μg/ml. Protocols & Applications Antibiotic Selector for application, solubility, solution stability, working concentration, and mode of action information |
Sigma Aldrich -
15821
|
Components (per vial, sufficient for 500 ml medium)Carbenicillin 25 mg Application For selective isolation and detection of Klebsiella species. Biochem/physiol Actions The antibiotic carbenicillin, an ampicillin analog, is a commonly used selection agent that binds and inhibits enzymes involved in the synthesis of the bacterial cell wall. It is active against most isolates of Pseudomonas aerogenosa and certain indole-positive Proteus strains that are resistant to ampicillin. The gene conferring resistance to ampicillin and its analogs, ampr, codes for the enzyme β-lactamase. Carbenicillin is less sensitive to β-lactamase than ampicillin. In addition it has a superior stability at low pH. Experiments have shown that the use of carbenicillin in place of ampicillin helps prevent overgrowth of satellite colonies. Effective concentration: 50 to 100 μg/ml. Other Notes Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. 15821.pdf Tested metabolites are featured on Scripps Center for Metabolomics METLIN Metabolite Database. To learn more, visit sigma.com/metlin. |
PATENTS
PATENTS
PubChem Patent
Google Patent